Advanced Drug Delivery Strategies for Respiratory Diseases PhD Scholarship – Eligibility, Benefits & How to Apply

🌟 About the Scholarship

Opens
Closes31 Jul, 2026

The Advanced Drug Delivery Strategies for Respiratory Diseases Scholarship is a fully funded PhD research scholarship offered by the NICM Health Research Institute at Western Sydney University, Australia. The scholarship provides full financial support for the successful PhD candidate throughout the approved funding period. In addition, scholars receive access to world-class research facilities, advanced laboratory equipment, and expert academic supervision at the NICM Health Research Institute. They also gain practical experience in formulation development, nanoparticle technology, pulmonary drug delivery, physicochemical characterization, and analytical assessment techniques. Furthermore, the project offers opportunities to collaborate with leading researchers and develop valuable research, technical, and professional skills. Consequently, recipients build a strong foundation for successful careers in pharmaceutical research and innovation.

🎓 Scholarship Snapshot

Here’s everything you need at a glance: the documents to prepare, what the award covers, and key dates so you don’t miss a beat. From transcripts and essays to tuition and living support, this gives you a clear picture of the Advanced Drug Delivery Strategies for Respiratory Diseases PhD Scholarship before you apply.

Eligible Countries

Afghanistan, Albania, Algeria, Andorra, Angola, Antigua and Barbuda, Argentina, Armenia, Aruba, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Benin, Bhutan, Bolivia, Bosnia-Herzegovina, Botswana, Brazil, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cabo Verde, Cambodia, Cameroon, Canada, Cape Verde, Central African Republic, Chad, Chile, China, Colombia, Comoros, Costa Rica, Côte d’Ivoire, Croatia, Cuba, Cyprus, Czech Republic, Democratic Republic of the Congo, Denmark, Djibouti, Dominica, Dominican Republic, East Timor, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Eswatini, Ethiopia, Fiji, Finland, France, Gabon, Gambia, Georgia, Germany, Ghana, Greece, Greenland, Grenada, Guam, Guatemala, Guinea, Guinea Bissau, Guyana, Haiti, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, Kosovo, Kuwait, Kyrgyzstan, Lao People’s Democratic Republic, Laos, Latvia, Lebanon, Lesotho, Liberia, Libya, Liechtenstein, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia, Moldova, Monaco, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Netherlands, New Zealand, Nicaragua, Niger, Nigeria, Niue, North Korea, North Macedonia, Norway, Oman, Pakistan, Palau, Palestine, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Puerto Rico, Qatar, Romania, Russia, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Scotland, Seirra Leone, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, South Korea, South Sudan, South-Africa, Spain, Sri Lanka, Sudan, Suriname, Swaziland, Sweden, Switzerland, Syrian Arab Republic, Taiwan, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tokelau, Trinidad-Tobago, Tunisia, Turkey, Tuvalu, Uganda, Ukraine, United Arab Emirates, United Kingdom, United States, Uruguay, Uzbekistan, Vanuatu, Vatican City, Venezuela, Vietnam, Wales, Yemen, Zambia, Zimbabwe

Study Fields

Health Sciences, Pharmaceutical Sciences

GPA / Grade

GPA 3.0

Languages

IELTS 6.5, PTE A 58, TOEFL iBT 82

Tests

Study Levels

Doctoral, PhD

Total Scholarships

Transcripts

Yes

Degrees

Yes

Essay

Yes

Passport ID

Recommendation Letters

Yes (1)

Result Date

Program Start

2027

Tuition Fee

Covered

Living Allowance

Yes

AUD 35,188/year

Travel Allowance

Research Grant

Health Insurance

Visa Assistance

📞 Contact Information

Call if you want a quick answer, send an email for detailed questions, or follow the university’s social channels to keep an eye on updates and reminders. Use whatever fits your style and timezone.

Scholarship Summary

Award AmountAUD 35,188/year
Deadline31 Jul, 2026
LevelDoctoral, PhD
InstitutionWestern Sydney University
CountryAustralia
ModeOnline
TypeFully funded

Apply Now

The Advanced Drug Delivery Strategies for Respiratory Diseases Scholarship is a fully funded PhD research scholarship offered by the NICM Health Research Institute at Western Sydney University, Australia. The project focuses on developing innovative drug delivery systems for the treatment of respiratory diseases by incorporating plant-derived phytoceuticals into advanced pulmonary delivery platforms. Moreover, the scholarship allows doctoral researchers to work in a multidisciplinary environment that combines pharmaceutics, nanotechnology, pulmonary biology, and pharmaceutical sciences. Through this research, scholars develop advanced scientific skills while contributing to new treatment approaches for respiratory diseases.

Background and Purpose

The scholarship aims to improve the treatment of respiratory diseases by developing targeted drug delivery technologies that enhance the effectiveness of plant-based therapeutic compounds. The research addresses major challenges associated with phytoceuticals, including poor solubility, limited bioavailability, and rapid degradation. Furthermore, the project integrates modern pharmaceutical technologies with innovative formulation strategies to improve drug stability and therapeutic performance. It also encourages collaboration across multiple scientific disciplines to accelerate the development of effective respiratory therapies. As a result, the research supports the advancement of safer, more efficient treatments for patients while contributing to global pharmaceutical innovation.

Advanced Drug Delivery Strategies for Respiratory Diseases PhD Scholarship Benefits

The scholarship provides full financial support for the successful PhD candidate throughout the approved funding period. In addition, scholars receive access to world-class research facilities, advanced laboratory equipment, and expert academic supervision at the NICM Health Research Institute. They also gain practical experience in formulation development, nanoparticle technology, pulmonary drug delivery, physicochemical characterization, and analytical assessment techniques. Furthermore, the project offers opportunities to collaborate with leading researchers and develop valuable research, technical, and professional skills. Consequently, recipients build a strong foundation for successful careers in pharmaceutical research and innovation.

Eligibility Criteria

Applicants must satisfy the admission requirements for a PhD program at Western Sydney University. Additionally, they should demonstrate an excellent academic record and possess a strong background in pharmaceutical sciences, pharmaceutics, nanotechnology, biomedical sciences, chemistry, or a closely related discipline. Candidates with research experience in drug delivery systems, formulation science, or pulmonary therapeutics may receive preference. Furthermore, applicants should demonstrate strong research potential, analytical skills, and the ability to work effectively in a multidisciplinary research environment.

Advanced Drug Delivery Strategies for Respiratory Diseases PhD Scholarship Application Process

Eligible applicants must apply for admission to the PhD program and submit the required scholarship application documents according to Western Sydney University’s guidelines. The selection committee evaluates candidates based on their academic achievements, research experience, technical skills, and suitability for the project. Shortlisted applicants may also participate in interviews before the university makes the final selection. Successful candidates then begin their research under the supervision of Professor Kamal Dua at the NICM Health Research Institute.

Opportunities for Scholars

The scholarship enables researchers to contribute to the development of advanced pulmonary drug delivery technologies with significant clinical applications. As a result, scholars gain expertise in nanomedicine, respiratory therapeutics, pharmaceutical formulation, and translational research. Furthermore, they work on innovative technologies involving nanoparticles, liposomes, and dry powder inhalers while collaborating with internationally recognized researchers. Their work also supports the development of improved treatments for asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Ultimately, the scholarship prepares graduates for rewarding careers in academia, research institutes, biotechnology organizations, and the global pharmaceutical industry.

Frequently Asked Questions (FAQs)

Who is eligible?

Applicants must meet Western Sydney University’s PhD admission requirements and hold a First Class Honors degree, a research master’s degree, or an equivalent qualification in pharmaceutics, drug delivery, pharmacology, immunology, microbiology, or a related field.

How do I apply?

Applicants must submit an Expression of Interest (EOI) to the lead supervisor, Professor Kamal Dua, before submitting a full scholarship application through Western Sydney University. The EOI should be submitted at least five business days before the application deadline.

What is the focus of the research project?

The project focuses on developing advanced drug delivery systems, including nanoparticles, liposomes, and dry powder inhalers, to improve the delivery of phytoceuticals for treating respiratory diseases such as asthma and COPD.